Psychiatric Assessment and Medication Review in London

A psychiatric assessment in London can help clarify a mental health problem, consider medical and psychological treatment, and review how existing medicines are working. It should produce an understandable explanation and a follow-up plan. A consultation is not simply a route to obtaining a prescription, and a medication review does not automatically mean that treatment will be changed.

The key distinction is between understanding the clinical problem and deciding what to do about it. Both require the person’s history, current circumstances, preferences, and relevant records. If a psychiatrist recommends medication, the plan also needs to establish who prescribes, who monitors its effects, and who responds when concerns arise.

Understand the psychiatrist’s role

A psychiatrist is a medical doctor working in mental health. The Royal College of Psychiatrists explains the different professional roles and referral routes. In the NHS, a referral commonly enters a mental health team first; another team member may assess the person before a psychiatrist becomes involved.

Different psychiatrists have different areas of expertise. An adult general psychiatry consultation, an addiction assessment, an ADHD diagnostic assessment, and a specialist eating disorder opinion may require different experience and supporting information. Ask whether the clinician’s practice matches the question you need answered.

Use the GMC register to check the doctor’s identity, registration, and relevant specialist information. The credentials guide explains how to interpret professional and service records. A clinic address or membership title alone should not carry the whole assessment of competence.

Give the consultation a clear clinical question

Before attending, write down why you want the review now. Perhaps the diagnosis has remained uncertain, a previous treatment has not helped enough, or side effects are interfering with everyday life. A focused question helps organize the consultation without limiting the psychiatrist’s ability to explore other relevant concerns.

For example, “I still cannot return to work despite treatment” is more informative than simply requesting a different medicine. It invites discussion of symptoms, functioning, the treatment already tried, and barriers outside medication. Likewise, “I feel too drowsy to manage mornings” describes a problem that needs assessment rather than specifying the answer in advance.

The first assessment guide covers general preparation. For a psychiatric opinion, bring previous clinic letters, discharge summaries, relevant test results, and a current medication list where available. Tell the clinic if records are missing so it can explain what is needed before making particular decisions.

Diagnosis depends on the pattern over time

The psychiatrist may ask when difficulties began, whether they occur in episodes, how they affect functioning, and how they relate to sleep, substance use, medication, or physical illness. The NHS assessment information describes a broad discussion of mental and physical health, circumstances, and support needs.

A timeline can help distinguish a longstanding problem from a recent change. Include periods when you felt better and what was different then. If another person noticed changes that you did not recognize at the time, explain that too, while making clear whose account is being described.

A single appointment may leave some uncertainty. Ask what possibilities are being considered, what additional information could clarify them, and whether treatment can begin while the question is explored. A careful provisional explanation can be more useful than a confident label that does not account for the history.

Medication reconciliation and medication review are different tasks

NICE’s medicines optimization guidance distinguishes making an accurate medication record from reviewing treatment. Reconciliation establishes what the person is actually taking and resolves discrepancies. A review considers whether the medicines remain appropriate, beneficial, acceptable, and practical for the person.

Bring information about medicines from every prescriber, including nonprescription products and supplements. Note the prescribed instructions and how use differs in practice. If you cannot remember a name, a recent pharmacy list or labeled packaging may help the clinician verify it. Do not guess a medicine or dose to complete a form.

Include treatments that were stopped and why. A medicine described as ineffective may have been stopped early because of side effects, cost, or difficulty collecting it. Another may have helped one symptom while creating a different problem. Those distinctions affect the clinical discussion and should not be lost in a simple list of past prescriptions.

A review considers function as well as symptom scores

NHS England describes structured medication reviews as considering the person’s wider health. Ask how benefit will be judged in your situation. A symptom scale can be informative, but the discussion should also consider what has changed in sleep, relationships, concentration, work, or ordinary activities.

Keep observations specific. Instead of “the medicine is bad,” describe what happens, when it began, and how it affects you. Instead of “nothing works,” explain what improved and what did not. You do not need to prove that a medicine caused a problem before raising it; the clinician can help examine possible explanations.

Ask what information is needed before a change is considered. Depending on the medicine and clinical situation, that might include physical observations, laboratory tests, a review of another prescription, or discussion with an existing clinician. Do not assume every psychiatric medicine requires the same monitoring or that a standard test package answers every question.

Also ask what remains outside the medication plan. If distress has eased but you are still avoiding ordinary activities, the next question may concern psychological treatment or practical support as well as prescribing. A review should help identify those remaining needs rather than using medication change as the only measure of progress.

Discuss options without making abrupt changes yourself

A review may lead to continuing the current plan, adjusting it, considering another treatment, or obtaining more information. NICE’s shared decision-making guidance supports discussing benefits, harms, alternatives, and the person’s priorities. Ask what the proposed change is intended to achieve and how its effect will be reviewed.

NICE’s guidance on medicines associated with dependence or withdrawal covers particular medication groups, including benzodiazepines and antidepressants, with different issues for each. Do not assume all psychiatric medicines are addictive or that stopping them is straightforward. Discuss any reduction or discontinuation with the responsible prescriber.

If the plan changes, ask for clear written instructions and whom to contact if the instructions are unclear or problems develop. This guide does not provide dosing or tapering schedules. The appropriate plan depends on the medicine, the reason it is used, previous experiences, and the person’s clinical needs.

Alcohol and drug use belong in the medication discussion

Tell the psychiatrist about alcohol, drugs, and medicines obtained outside the current prescription system. These can affect assessment, treatment choices, and safety. The current UK alcohol guidance emphasizes coordinated care when mental health and alcohol-related needs coexist.

The dual diagnosis guide explains how that coordination can work across services. Ask which clinician manages psychiatric treatment, which manages substance-related care, and how they communicate. A person should not have to decide between conflicting instructions from two teams without help resolving them.

For ADHD medication questions, the ADHD care guide discusses assessment and prescribing continuity. The relevant question is how the individual’s needs and risks are assessed, not whether a broad label automatically establishes eligibility or rules treatment out.

Shared care requires an actual agreement

The GMC states that shared care requires agreement from all parties, including the patient. A private psychiatrist’s letter recommending medication does not automatically mean the GP has agreed to prescribe it. Ask who remains responsible until any proposed handover is accepted.

The agreement should explain monitoring, specialist follow-up, how concerns are communicated, and what happens if the treatment needs changing. The BMA’s current shared-care guidance also emphasizes ongoing specialist input and clear responsibilities. Confirm the arrangements with the actual practices involved rather than relying on a general clinic statement.

For private care, ask about the continuing cost if prescribing and monitoring remain private. An affordable first consultation may be only one part of the overall commitment. Include review appointments, prescriptions, tests, and communication fees in the discussion where they apply.

Arrange follow-up and a route for concerns

Before leaving, confirm the next review, the purpose of any tests, and who explains the results. Ask what changes should prompt earlier contact and which service to use outside routine hours. A prescription without an accessible follow-up arrangement leaves an important part of treatment undefined.

If the explanation does not fit your experience, identify the specific concern and ask for clarification or another opinion. You may need more time to consider options. The consultation should leave you able to describe the current plan in your own words and know who is responsible for the next decision.

For urgent deterioration, follow any existing crisis plan and contact the relevant service. The urgent assessment guide explains NHS routes, including NHS 111’s mental health option in England and 999 for immediate danger or a medical emergency. Do not wait for a routine medication review when urgent assessment is needed.